NCT06145490View on ClinicalTrials.gov

Neurobehavioral Correlates of Caffeine on Anxiety, Avoidance and Interoception in Healthy Individuals and Panic Disorder.

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 29, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Panic DisorderHealthy
Interventions
DIETARY_SUPPLEMENT

Caffeine

Caffeine capsule 250 mg, oral intake

DRUG

Placebo

Placebo capsule, oral intake

Trial Locations (2)

75185

RECRUITING

Uppsala University, Department of Medical Sciences, Psychiatry, Uppsala

Unknown

RECRUITING

National 7T Facility - Lunds universitet, Lund

All Listed Sponsors
lead

Uppsala University

OTHER